(JAZZ) Jazz Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Jazz Pharmaceuticals | (JAZZ) share price targets
Complete technical analysis of Jazz Pharmaceuticals (JAZZ) by charts plus indicators, forecast predictions and share price targets for Jazz Pharmaceuticals (JAZZ)
Jazz Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-03-06 View latest technical analysis
10 day averaged volume of Jazz Pharmaceuticals is 791240
| Date | Daily Closing Price | Open | High | Low | Volume |
| 06 Wed Mar 2024 | 117.19 | 120.85 | 122.11 | 116.82 | 0.928 times |
| 05 Tue Mar 2024 | 118.42 | 117.40 | 119.50 | 116.67 | 0.989 times |
| 04 Mon Mar 2024 | 117.53 | 119.06 | 120.00 | 115.64 | 1.389 times |
| 01 Fri Mar 2024 | 118.85 | 119.65 | 122.57 | 118.54 | 1.32 times |
| 29 Thu Feb 2024 | 118.90 | 125.50 | 125.50 | 116.00 | 2.848 times |
| 28 Wed Feb 2024 | 129.70 | 132.18 | 132.85 | 129.18 | 0.882 times |
| 27 Tue Feb 2024 | 132.26 | 133.20 | 133.36 | 131.13 | 0.571 times |
| 26 Mon Feb 2024 | 132.77 | 131.81 | 134.17 | 131.81 | 0.698 times |
| 23 Fri Feb 2024 | 132.28 | 128.88 | 132.44 | 128.05 | 0.488 times |
| 22 Thu Feb 2024 | 128.45 | 128.42 | 128.63 | 126.09 | 0.434 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 119.7, but if it comes above 119.7, then a intra day buy could be more profitable.
If you take a sell trade below 119.7, then use 119.7 as stoploss and 113.8 as target. However if you take a buy trade in stock , then use 119.7 as stoploss and 124.6 as target.
Share price targets for Jazz Pharmaceuticals (JAZZ)
| Target Type | Value |
| Downside Target | 111.25 |
| Downside Target | 113.55 |
| Upside Target | 120.64 |
| Upside Target | 125.58 |
| Upside Target | 125.80 |
| Upside Target | 126.86 |
| Upside Target | 127.79 |
| Upside Target | 129.31 |
| Upside Target | 132.44 |
| Upside Target | 134.17 |
| Upside Target | 134.48 |
Intraday share price targets for Jazz Pharmaceuticals (JAZZ)
| Target Type | Value |
| Downside Intraday Target | 114.52 |
| Downside Intraday Target | 111.84 |
| Upside Intraday Target | 120.99 |
| Upside Intraday Target | 124.78 |
| Upside Intraday Target | 118.31 |
Weekly technical analysis of Jazz Pharmaceuticals (JAZZ)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 06 Wed Mar 2024 | 117.19 | 119.06 | 122.11 | 115.64 | 0.523 times |
| 01 Fri Mar 2024 | 118.85 | 131.81 | 134.17 | 116.00 | 2.996 times |
| 23 Fri Feb 2024 | 132.28 | 126.88 | 132.44 | 125.58 | 0.696 times |
| 16 Fri Feb 2024 | 126.78 | 123.43 | 127.79 | 120.64 | 1.449 times |
| 09 Fri Feb 2024 | 123.43 | 122.66 | 125.80 | 120.71 | 0.587 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Jazz Pharmaceuticals (JAZZ)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 06 Wed Mar 2024 | 117.19 | 119.65 | 122.57 | 115.64 | 0.343 times |
| 29 Thu Feb 2024 | 118.90 | 122.52 | 134.17 | 116.00 | 0.804 times |
| 31 Wed Jan 2024 | 122.72 | 122.45 | 129.31 | 113.55 | 1.015 times |
| 29 Fri Dec 2023 | 123.00 | 117.94 | 126.86 | 116.00 | 0.766 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Jazz Pharmaceuticals (JAZZ)
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Jazz Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Jazz Pharmaceuticals in short term and the sell signal is strong.
Jazz Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Jazz Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Jazz Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 122.07 and Jazz Pharmaceuticals (JAZZ) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Jazz Pharmaceuticals (JAZZ) stock. Volume based technical analysis of Jazz Pharmaceuticals (JAZZ) stock is negative.
Jazz Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Jazz Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Jazz Pharmaceuticals in short term and the sell signal is strong.
Jazz Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Jazz Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Jazz Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 122.07 and Jazz Pharmaceuticals (JAZZ) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Jazz Pharmaceuticals (JAZZ) stock. Volume based technical analysis of Jazz Pharmaceuticals (JAZZ) stock is negative.
Jazz Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.